NEUROPATHOLOGY CORE The Neuropathology Core (NPC) coordinates and carries out the technical procedures related to the neuropathologic tissue-based studies that are essential to the University of Kansas Alzheimer Disease Center (ADC) study subjects enrolled in the Clinical Core. The Core neuropathologist oversees the pathologic examination of the brain and prepares a diagnostic report for the family, physicians, and the National Alzheimer's Coordinating Center. The NPC prepares the brain tissue in a systematic way, using standardized protocols and diagnostic criteria, in order to facilitate good correlations among other ADCs, and to maximize research potential. In addition, to the brain we also collect muscle and skin biopsies, if the family agrees. The brain tissue collection is coded to protect privacy, organized, monitored, and safeguarded. As the KU ADC Study is still relatively young, we have a small number of cases in our repository, but we already have many researchers who are interested in obtaining brain tissue. The Core provides neuropathologic professional and technical expertise about AD/other neurodegenerative disease on an individualized basis to researchers. The NPC personnel frequently communicate with family members of Clinical Core participants or others outside of the study who are interested in our program. We place high value on education and hold teaching conferences and presentations where we educate physicians, nurses, and trainees about Alzheimer disease, other dementias, and aging. We have a growing interest in the correlation of neuroimaging and neuropathology findings. Toward that goal, we have a neuroradiologist consultant who helps in teaching about brain MR imaging. To contribute to national and international research studies of AD and related disorders, we assist in autopsies of subjects who have enrolled in studies, such as Alzheimer's Disease Neuroimaging Initiative (ADNI), and the Dominantly Inherited Alzheimer Network (DIAN.) Because of our ADC's focus on metabolic disease, the NPC Core is working with a consultant who is an expert in the use of a unique imaging technique that has been used to detect metabolic changes in brain. We hope this approach may lead to new information about the brain metabolism in AD and/or aging.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kansas
Kansas City
United States
Zip Code
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Belousov, Andrei B; Nishimune, Hiroshi; Denisova, Janna V et al. (2018) A potential role for neuronal connexin 36 in the pathogenesis of amyotrophic lateral sclerosis. Neurosci Lett 666:1-4
Roth, Alexandra K; Denney, Douglas R; Burns, Jeffrey M et al. (2018) Cognition in older patients with multiple sclerosis compared to patients with amnestic mild cognitive impairment and healthy older adults. Neuropsychology 32:654-663
Khan, Tarique; Kandola, Tejbir S; Wu, Jianzheng et al. (2018) Quantifying Nucleation In Vivo Reveals the Physical Basis of Prion-like Phase Behavior. Mol Cell 71:155-168.e7
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Koppel, Scott J; Swerdlow, Russell H (2018) Neuroketotherapeutics: A modern review of a century-old therapy. Neurochem Int 117:114-125

Showing the most recent 10 out of 333 publications